MELK promotes HCC cell migration by upregulating MMP7 expression and regulates G2/M phase progression via PLK1-CDC25-CDK signaling, thereby inhibiting apoptosis (38). The gene discussed is PLK1; the disease is hepatocellular carcinoma.